COMMUNITY MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Scranton, PA
- Medicare CCN
- 390001
- Received
- $37,683 in 5 records, 2020 ($34,327 general, $3,355 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Community Medical Center Fuzzy (name and state)
- Business registration: Community Medical Center Fuzzy (name and state)
- Federal award recipient: COMMUNITY MEDICAL CENTER, THE Fuzzy (name and state)
- Lobbying client: COMMUNITY MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: COMMUNITY MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: COMMUNITY MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 3 | $34,327 |
| 2020 | Research payment | 2 | $3,355 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Olympus America Inc. | 1 | $21,603 | 2020 |
| Linvatec Corporation | 1 | $6,498 | 2020 |
| ACELL, INC. | 1 | $6,225 | 2020 |
| Boehringer Ingelheim Pharma GmbH & Co.KG | 2 | $3,355 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Education | 2 | $27,828 |
| Grant | 1 | $6,498 |
| Research payment | 2 | $3,355 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Linvatec Corporation | $6,498 | Grant | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-31 | Boehringer Ingelheim Pharma GmbH & Co.KG | $3,049 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Safety & Efficacy of Empa in patients with Acute HF | 2020 |
| 2020-08-26 | Boehringer Ingelheim Pharma GmbH & Co.KG | $306 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Safety & Efficacy of Empa in patients with Acute HF | 2020 |
| 2020-06-14 | Olympus America Inc. | $21,603 | Education | In-kind items and services | Camera Heads Device, Urology/Gynecology | 2020 | |
| 2020-04-29 | ACELL, INC. | $6,225 | Education | Cash or cash equivalent | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
Comments